Pharma-Bio Serv (PBSV) Current Assets (2016 - 2025)
Historic Current Assets for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $13.4 million.
- Pharma-Bio Serv's Current Assets fell 1472.67% to $13.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $13.4 million, marking a year-over-year decrease of 1472.67%. This contributed to the annual value of $13.4 million for FY2025, which is 1472.67% down from last year.
- As of Q4 2025, Pharma-Bio Serv's Current Assets stood at $13.4 million, which was down 1472.67% from $13.2 million recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's Current Assets ranged from a high of $28.9 million in Q1 2021 and a low of $13.2 million during Q3 2025
- In the last 5 years, Pharma-Bio Serv's Current Assets had a median value of $19.3 million in 2022 and averaged $19.3 million.
- As far as peak fluctuations go, Pharma-Bio Serv's Current Assets skyrocketed by 1748.62% in 2021, and later tumbled by 2852.06% in 2022.
- Quarter analysis of 5 years shows Pharma-Bio Serv's Current Assets stood at $22.8 million in 2021, then fell by 12.61% to $19.9 million in 2022, then decreased by 2.72% to $19.4 million in 2023, then decreased by 19.08% to $15.7 million in 2024, then decreased by 14.73% to $13.4 million in 2025.
- Its Current Assets was $13.4 million in Q4 2025, compared to $13.2 million in Q3 2025 and $13.4 million in Q2 2025.